2025 Q4 -tulosraportti
Vain PDF
57 päivää sitten
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 646 | - | - | ||
| 200 | - | - | ||
| 65 | - | - | ||
| 70 | - | - | ||
| 1 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 268 917 | 268 917 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 268 917 | 268 917 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 26.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·10 min sittenIf NN now showed the REAL price and not the last traded price, then one could better believe in NN, it doesn't make sense to show anything other than what the stock is worth. The other is lame and a scam price which constantly proves that someone wants to defraud. We are constantly at zero OR minus 🥱🥱🥱🥱- ·2 päivää sittenReally several percent down if one is to sell just a few thousand shares SO THE PRICE MANIPULATION IS COMPLETELY INTACT
·3 päivää sittenStig B. Try to take a look at Ascelia, Gentian and Observe Medicals
·2 päivää sittenHmm - as a high risk/reward position, Observe could be a bit fun, if they can partially reclaim the Convatec market. Sounds like a bit of a task, though, and it also seems that execution power is low - both resource-wise and experience-wise when looking at the organization (management, size, and board). I'll have to look into that a bit more - but it sounds fun/exciting. Gantian, I need to look into a bit more - it seems to be more of a "proven case".- ·3 päivää sitten · MuokattuThere's quite a hard fight against the "market" to keep it above 15.00 - they're trying everything - 1-100 pcs at the lowest selling price to briefly give it a "hop". Quite silly to take 45 pcs at 15.26, when the last trade was at 15.11 :-). Gross "manipulation" :-) to prevent me from getting the last ones within my buying window of 12-15, where it rightfully belongs at the moment :-) :-). A tough battle is being fought between "fantasists" and "realists" - the "fantasists" briefly had the upper hand for a few months, but it looks like the "realists" have fought their way back into the fight - incredibly exciting to follow :-). Got quite annoyed yesterday, so was "tempted" to take a chunk at 15.06 - but I think maybe today I can get another chunk between 14.5 and 15.00 - it's unlikely to go down further before Medix finally gives up on Tesofensine or Cofepris rejects it again - I just need to make room to grab the last ones I want at the current risk level in Saninoa's pipeline. Otherwise, there's been good progress with those I considered more exciting in the 6-12 month term, and where some of the Saniona proceeds from Oct-Jan were placed (Infant Bacterial, Moberg, AcuCort, Xvivo, Vicore, Egetis - Hansa is still lagging a bit).·4 t sitten · MuokattuCongratulations. I've also bought. How big was the chunk then ;) 250 shares?·4 t sitten · Muokattu:-) - 500 - I'm aiming to only have 10,000 at the current risk level - that was the amount I actually would have liked to have kept when I sold everything - I'm missing 2,000 which I have placed orders for at 14 - 13.5 and 12.5. I think I'll get the first 2 - but probably not 12.5 unless TESO is rejected or dropped by Medix. But but - with a rather small probability I see the following scenario as possible - it is my most pessimistic scenario among several possible outcomes in the next 6-12 months A) Teso is rejected by Cofepris/Stopped by Medix B) no new agreements C) 1 of the 3 inhouse projects is dropped and does not enter clinical phase D) partner milestones are delayed into 2027 E) Cash burn increases significantly due to preparation and start-up of clinical phase for the 2 remaining inhouse projects. It is a very pessimistic scenario - and not the most likely - but the risk is not 0.00. And where will the price then be in 9-12 months ??! It has an impact on 1) how large a proportion of my PF I dare to put into Saniona 2) how large a proportion of this proportion I want to buy now 3) what price I will pay now Remember increasing risk = falling price / falling risk = increasing price I will not buy more at higher risk/lower price - but gladly at lower risk/higher price. So the price might be 35 at some point - but then I will also have bought along the way and might have GAK 20 instead of the current 14.8 - but that's fine too. The only thing I miss here is a take-over bid (and I don't think that will happen for now - and I'm not investing based on that either) or a temporary hype from a new agreement - but as mentioned, I expect it to fall back to a new "normal" after a period, which I can then buy at - and otherwise I just won't get more - and then I have to hope the others I bought instead have risen similarly or more.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
57 päivää sitten
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·10 min sittenIf NN now showed the REAL price and not the last traded price, then one could better believe in NN, it doesn't make sense to show anything other than what the stock is worth. The other is lame and a scam price which constantly proves that someone wants to defraud. We are constantly at zero OR minus 🥱🥱🥱🥱
- ·2 päivää sittenReally several percent down if one is to sell just a few thousand shares SO THE PRICE MANIPULATION IS COMPLETELY INTACT
- ·3 päivää sittenStig B. Try to take a look at Ascelia, Gentian and Observe Medicals·2 päivää sittenHmm - as a high risk/reward position, Observe could be a bit fun, if they can partially reclaim the Convatec market. Sounds like a bit of a task, though, and it also seems that execution power is low - both resource-wise and experience-wise when looking at the organization (management, size, and board). I'll have to look into that a bit more - but it sounds fun/exciting. Gantian, I need to look into a bit more - it seems to be more of a "proven case".
- ·3 päivää sitten · MuokattuThere's quite a hard fight against the "market" to keep it above 15.00 - they're trying everything - 1-100 pcs at the lowest selling price to briefly give it a "hop". Quite silly to take 45 pcs at 15.26, when the last trade was at 15.11 :-). Gross "manipulation" :-) to prevent me from getting the last ones within my buying window of 12-15, where it rightfully belongs at the moment :-) :-). A tough battle is being fought between "fantasists" and "realists" - the "fantasists" briefly had the upper hand for a few months, but it looks like the "realists" have fought their way back into the fight - incredibly exciting to follow :-). Got quite annoyed yesterday, so was "tempted" to take a chunk at 15.06 - but I think maybe today I can get another chunk between 14.5 and 15.00 - it's unlikely to go down further before Medix finally gives up on Tesofensine or Cofepris rejects it again - I just need to make room to grab the last ones I want at the current risk level in Saninoa's pipeline. Otherwise, there's been good progress with those I considered more exciting in the 6-12 month term, and where some of the Saniona proceeds from Oct-Jan were placed (Infant Bacterial, Moberg, AcuCort, Xvivo, Vicore, Egetis - Hansa is still lagging a bit).·4 t sitten · MuokattuCongratulations. I've also bought. How big was the chunk then ;) 250 shares?·4 t sitten · Muokattu:-) - 500 - I'm aiming to only have 10,000 at the current risk level - that was the amount I actually would have liked to have kept when I sold everything - I'm missing 2,000 which I have placed orders for at 14 - 13.5 and 12.5. I think I'll get the first 2 - but probably not 12.5 unless TESO is rejected or dropped by Medix. But but - with a rather small probability I see the following scenario as possible - it is my most pessimistic scenario among several possible outcomes in the next 6-12 months A) Teso is rejected by Cofepris/Stopped by Medix B) no new agreements C) 1 of the 3 inhouse projects is dropped and does not enter clinical phase D) partner milestones are delayed into 2027 E) Cash burn increases significantly due to preparation and start-up of clinical phase for the 2 remaining inhouse projects. It is a very pessimistic scenario - and not the most likely - but the risk is not 0.00. And where will the price then be in 9-12 months ??! It has an impact on 1) how large a proportion of my PF I dare to put into Saniona 2) how large a proportion of this proportion I want to buy now 3) what price I will pay now Remember increasing risk = falling price / falling risk = increasing price I will not buy more at higher risk/lower price - but gladly at lower risk/higher price. So the price might be 35 at some point - but then I will also have bought along the way and might have GAK 20 instead of the current 14.8 - but that's fine too. The only thing I miss here is a take-over bid (and I don't think that will happen for now - and I'm not investing based on that either) or a temporary hype from a new agreement - but as mentioned, I expect it to fall back to a new "normal" after a period, which I can then buy at - and otherwise I just won't get more - and then I have to hope the others I bought instead have risen similarly or more.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 646 | - | - | ||
| 200 | - | - | ||
| 65 | - | - | ||
| 70 | - | - | ||
| 1 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 268 917 | 268 917 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 268 917 | 268 917 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 26.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
2025 Q4 -tulosraportti
Vain PDF
57 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 26.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·10 min sittenIf NN now showed the REAL price and not the last traded price, then one could better believe in NN, it doesn't make sense to show anything other than what the stock is worth. The other is lame and a scam price which constantly proves that someone wants to defraud. We are constantly at zero OR minus 🥱🥱🥱🥱
- ·2 päivää sittenReally several percent down if one is to sell just a few thousand shares SO THE PRICE MANIPULATION IS COMPLETELY INTACT
- ·3 päivää sittenStig B. Try to take a look at Ascelia, Gentian and Observe Medicals·2 päivää sittenHmm - as a high risk/reward position, Observe could be a bit fun, if they can partially reclaim the Convatec market. Sounds like a bit of a task, though, and it also seems that execution power is low - both resource-wise and experience-wise when looking at the organization (management, size, and board). I'll have to look into that a bit more - but it sounds fun/exciting. Gantian, I need to look into a bit more - it seems to be more of a "proven case".
- ·3 päivää sitten · MuokattuThere's quite a hard fight against the "market" to keep it above 15.00 - they're trying everything - 1-100 pcs at the lowest selling price to briefly give it a "hop". Quite silly to take 45 pcs at 15.26, when the last trade was at 15.11 :-). Gross "manipulation" :-) to prevent me from getting the last ones within my buying window of 12-15, where it rightfully belongs at the moment :-) :-). A tough battle is being fought between "fantasists" and "realists" - the "fantasists" briefly had the upper hand for a few months, but it looks like the "realists" have fought their way back into the fight - incredibly exciting to follow :-). Got quite annoyed yesterday, so was "tempted" to take a chunk at 15.06 - but I think maybe today I can get another chunk between 14.5 and 15.00 - it's unlikely to go down further before Medix finally gives up on Tesofensine or Cofepris rejects it again - I just need to make room to grab the last ones I want at the current risk level in Saninoa's pipeline. Otherwise, there's been good progress with those I considered more exciting in the 6-12 month term, and where some of the Saniona proceeds from Oct-Jan were placed (Infant Bacterial, Moberg, AcuCort, Xvivo, Vicore, Egetis - Hansa is still lagging a bit).·4 t sitten · MuokattuCongratulations. I've also bought. How big was the chunk then ;) 250 shares?·4 t sitten · Muokattu:-) - 500 - I'm aiming to only have 10,000 at the current risk level - that was the amount I actually would have liked to have kept when I sold everything - I'm missing 2,000 which I have placed orders for at 14 - 13.5 and 12.5. I think I'll get the first 2 - but probably not 12.5 unless TESO is rejected or dropped by Medix. But but - with a rather small probability I see the following scenario as possible - it is my most pessimistic scenario among several possible outcomes in the next 6-12 months A) Teso is rejected by Cofepris/Stopped by Medix B) no new agreements C) 1 of the 3 inhouse projects is dropped and does not enter clinical phase D) partner milestones are delayed into 2027 E) Cash burn increases significantly due to preparation and start-up of clinical phase for the 2 remaining inhouse projects. It is a very pessimistic scenario - and not the most likely - but the risk is not 0.00. And where will the price then be in 9-12 months ??! It has an impact on 1) how large a proportion of my PF I dare to put into Saniona 2) how large a proportion of this proportion I want to buy now 3) what price I will pay now Remember increasing risk = falling price / falling risk = increasing price I will not buy more at higher risk/lower price - but gladly at lower risk/higher price. So the price might be 35 at some point - but then I will also have bought along the way and might have GAK 20 instead of the current 14.8 - but that's fine too. The only thing I miss here is a take-over bid (and I don't think that will happen for now - and I'm not investing based on that either) or a temporary hype from a new agreement - but as mentioned, I expect it to fall back to a new "normal" after a period, which I can then buy at - and otherwise I just won't get more - and then I have to hope the others I bought instead have risen similarly or more.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 646 | - | - | ||
| 200 | - | - | ||
| 65 | - | - | ||
| 70 | - | - | ||
| 1 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 268 917 | 268 917 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 268 917 | 268 917 | 0 | 0 |